| Authors: |
Phillips EC; Department of Neuroscience, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, U.K., Croft CL; Department of Neuroscience, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, U.K., Kurbatskaya K; Department of Neuroscience, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, U.K., O'Neill MJ; †Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey GU20 6PH, U.K., Hutton ML; †Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey GU20 6PH, U.K., Hanger DP; Department of Neuroscience, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, U.K., Garwood CJ; ‡Department of Neuroscience, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2HQ, U.K., Noble W; Department of Neuroscience, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, U.K. |
